Hemogenyx Pharmaceuticals (HEMO)

Sector:

Pharma and Biotech

142.25p
   
  • Change Today:
    -2.75p
  • 52 Week High: 706.00p
  • 52 Week Low: 137.28p
  • Currency: UK Pounds
  • Shares Issued: 4.59m
  • Volume: 37,990
  • Market Cap: £6.53m
  • RiskGrade: 340

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Alexis M. Sandler 187,727 £267,042
Vladislav Sandler Ph.D. 103,862 £147,744
Peter Redmond 13,991 £19,902

Major Shareholders

Notifier** Holding Value*
Alexis Sandler 187,727 £267,042
Dr Vladislav Sandler 103,862 £147,744
Optiva Securities Limited 70,329 £100,043
Flascherberg Capital Anstalt 69,991 £99,562
Craig Auringer 59,593 £84,771
HSBC Client Holdings Nominee (UK) Limited 45,160 £64,240
Ron Valk 42,828 £60,923
Samantha Bauer 42,706 £60,749
Plum Capital 29,232 £41,582
43 North LLC 28,429 £40,440
Abdelatif LACHAB 6,500 £9,246
Wayne Gibson 6,500 £9,246

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HEMO Market Data

Currency UK Pounds
Share Price 142.25p
Change Today -2.75p
% Change -1.90 %
52 Week High 706.00p
52 Week Low 137.28p
Volume 37,990
Shares Issued 4.59m
Market Cap £6.53m
RiskGrade 340

HEMO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.32% below the market average45.32% below the market average45.32% below the market average45.32% below the market average45.32% below the market average
69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average69.57% below the sector average
Price Trend
94.26% below the market average94.26% below the market average94.26% below the market average94.26% below the market average94.26% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Income Not Available
Growth Not Available

HEMO Dividends

No dividends found

Trades for 11-Jul-2025

Time Volume / Share Price
16:29 14 @ 144.28p
16:26 500 @ 140.14p
16:23 267 @ 144.28p
16:20 681 @ 144.28p
16:05 1,000 @ 140.14p

HEMO Key Personnel

CEO Vladislav Sandler Ph.D.

Top of Page